Investigation and analysis of the charging status and standard of pharmacy intravenous admixture service in China
- VernacularTitle:我国静脉用药调配中心收费现状与收费标准调研分析
- Author:
Jie CAO
1
;
Xuefeng CAI
1
;
Yongning LYU
1
;
Jun CHEN
1
;
Yuqi FU
2
;
Lulu SUN
2
Author Information
1. Dept. of Pharmacy，Union Hospital，Tongji Medical College，Huazhong University of Science and Technology，Wuhan 430022，China
2. Dept. of Pharmaceutical Administration Research，National Institute of Hospital Administration，National Health Commission，Beijing 100044，China
- Publication Type:Journal Article
- Keywords:
pharmacy intravenous admixture service
- From:
China Pharmacy
2024;35(15):1807-1811
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate and analyze the operational costs and current charging policies of pharmacy intravenous admixture service （PIVAS） in China， and provide a reference for promoting high-quality and sustainable development of PIVAS. METHODS Questionnaires were distributed in 30 provinces， autonomous regions， and municipalities across the country through the “Wenjuanxing” platform from May 6th to July 1st， 2022. The operational costs， charging status and suggestions of PIVAS were investigated and analyzed. RESULTS A total of 761 PIVAS participated in the survey nationwide， including 666 tertiary medical institutions， 93 secondary medical institutions， and 2 primary medical institutions. Approximately 60.58% of PIVAS had implemented a charging system that allowed charges. Among them， most PIVAS required inspection and evaluation before charging. The annual operating cost of PIVAS in China was approximately 2 098 100 yuan， with the integrated operating cost comprising 89.36% of the total， while the dispensing cost accounted for only 10.64%. Human costs emerged as the highest annual consumption （74.20%）， followed by decoration and facility maintenance costs （4.77%） and equipment acquisition costs （3.44%）. Regarding charges for different drugs nationwide， common drugs had an average charge standard of 4.39 yuan per bag while antibacterial drugs averaged 5.01 yuan per bag； hazardous drugs had an average charge of 23.17 yuan per bag， whereas parenteral nutrition solutions averaged 38.75 yuan per bag. However， the recommended average charges of the four drugs mentioned above were 6.71， 9.63， 38.35 and 44.03 yuan per bag， respectively. CONCLUSIONS At present， there is no unified inspection and evaluation standard and charging standard in China. Moreover， the current charging standard is lower than the recommended standard. It is necessary to combine operational costs and develop more reasonable and fair charging standards.
